Multiple inflammatory cytokines such as TNFα, interleukin-6 (IL-6) and interleukin-1 (IL-1) are elevated in cachectic cancer hosts and are known to promote muscle catabolism, thus are considered therapeutic targets4. The gene discussed is IL6; the disease is cancer.